Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

FDG-PET/CT Metabolic Tumor Volume: A New Prognostic Marker in Hodgkin Lymphoma?

Marine Boulesteix, Mohamed Touati, Julie Abraham, Sandrine Verbeke, Assmae El Badaoui, Marie Pierre Gourin, Agnes Olivrie, Manuela Delage Corre, Benoit Marin, Arnaud Jaccard, Dominique Bordessoule, MD, PhD, Jacques Monteil

Blood (2012) 120 (21): 3632.

https://doi.org/10.1182/blood.V120.21.3632.3632

Published: 2012

Journal Articles

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

Arnaud Jaccard, Nathalie Gachard, Benoit Marin, Sylvie Rogez, Marie Audrain, Felipe Suarez, Hervé Tilly, Franck Morschhauser, Catherine Thieblemont, Loic Ysebaert, Alain Devidas, Barbara Petit, Laurence de Leval, Philippe Gaulard, Jean Feuillard, Dominique Bordessoule, Olivier Hermine, for the GELA and GOELAMS Intergroup

Blood (2011) 117 (6): 1834–1839.

https://doi.org/10.1182/blood-2010-09-307454

Published: 2011

Includes: Supplemental data

Journal Articles

HGF Measurement in AL Amyloidosis.

Julie Abraham, Estelle Desport, Benoit Marin, Sebastien Bender, Corinne Lacombe, Stéphane Girault, Stéphane Moreau, Fatima Yagoubi, Dominique Bordessoule, Franck Bridoux, Arnaud Jaccard

Blood (2009) 114 (22): 1783.

https://doi.org/10.1182/blood.V114.22.1783.1783

Published: 2009

Journal Articles

Non Predictive Value of An Initial Tc-99m-MIBI Scintigraphy On the Prediction of Therapeutic Outcome in Non Hodgkin and Hodgkin Lymphoma: Preliminary Results of a Prospective Study in 81 Patients .

Marie-Pierre Gourin, Jacques Monteil, Benoit Marin, Stéphane Girault, Natalya Dmytruk, Julie Abraham, Agnes Olivrie-Gamaury, Nicolas Weinbreck, Arnaud Jaccard, Jean Feuillard, Dominique Bordessoule, MD, PhD

Blood (2009) 114 (22): 4762.

https://doi.org/10.1182/blood.V114.22.4762.4762

Published: 2009

Journal Articles

Achievement a Negative 18-FDG/PET Status at the End of Procedure by Tailored Treatment According Pre-Transplantation Pet Status in Lymphomas Improve 5 Years-OS and EFS.

Dominique Bordessoule, Benoit Marin, Stéphane Girault, Fredericka Bompart, Julie Abraham, Natacha Dmytruck, Arnaud Jaccard, Jacques Monteil, Pascal Turlure

Blood (2008) 112 (11): 2193.

https://doi.org/10.1182/blood.V112.11.2193.2193

Published: 2008

NARROW

FDG-PET/CT Metabolic Tumor Volume: A New Prognostic Marker in Hodgkin Lymphoma?

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

HGF Measurement in AL Amyloidosis.

Non Predictive Value of An Initial Tc-99m-MIBI Scintigraphy On the Prediction of Therapeutic Outcome in Non Hodgkin and Hodgkin Lymphoma: Preliminary Results of a Prospective Study in 81 Patients .

Achievement a Negative 18-FDG/PET Status at the End of Procedure by Tailored Treatment According Pre-Transplantation Pet Status in Lymphomas Improve 5 Years-OS and EFS.

Email alerts

ASH Publications

American Society of Hematology

FDG-PET/CT Metabolic Tumor Volume: A New Prognostic Marker in Hodgkin Lymphoma?

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

HGF Measurement in AL Amyloidosis.

Non Predictive Value of An Initial Tc-99m-MIBI Scintigraphy On the Prediction of Therapeutic Outcome in Non Hodgkin and Hodgkin Lymphoma: Preliminary Results of a Prospective Study in 81 Patients .

Achievement a Negative 18-FDG/PET Status at the End of Procedure by Tailored Treatment According Pre-Transplantation Pet Status in Lymphomas Improve 5 Years-OS and EFS.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only